首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and in vitro antimicrobial activity of new 2-(p-substituted-benzyl)-5-(substituted-carbonylamino)benzoxazoles.
【24h】

Synthesis and in vitro antimicrobial activity of new 2-(p-substituted-benzyl)-5-(substituted-carbonylamino)benzoxazoles.

机译:新型2-(对-取代-苄基)-5-(取代-羰基氨基)苯并恶唑的合成及体外抗菌活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Some new 2-(benzyl/p-chlorobenzyl)-5-[(substituted-thienyl/phenyl/phenylthiomethyl/benzyl) carbonylamino]benzoxazole derivatives have been synthesized by reacting 5-amino-2-(benzyl/p-chlorobenzyl)benzoxazoles with appropriate carboxylic acid chlorides. The structures of the synthesized compounds were confirmed by IR, (1)H NMR and MASS spectral data. In vitro antimicrobial activities of the compounds were investigated using twofold serial dilution technique against different two Gram-positive, two Gram-negative bacteria and three Candida spp. in comparison with standard drugs. Microbiological results indicated that the newly synthesized 2-(benzyl/p-chlorobenzyl)-5-[(substituted-thienyl/phenyl/phenylthiomethyl/benzyl) carbonylamino]benzoxazole derivatives (3-12) possessed a broad spectrum of activity having MIC values of 6.25-100 microg/ml against the tested microorganisms. Especially, with an MIC value of 6.25 microg/ml, 2-(p-chlorophenyl)-5-[(2,5-dimethylphenyl)carbonylamino]benzoxazole 4 displayed thesame activity against Candida albicans as the standard drug clotrimazole.
机译:通过使5-氨基-2-(苄基/对氯苄基)苯并恶唑与5-氨基-2-(苄基/对氯苄基)苯并恶唑反应,合成了一些新的2-(苄基/对氯苄基)-5-[(取代的噻吩基/苯基/苯硫甲基/苄基)羰基氨基]苯并恶唑衍生物。适当的羧酸氯化物。通过IR,(1)H NMR和MASS光谱数据确认了合成化合物的结构。使用双重系列稀释技术研究了该化合物对不同的两种革兰氏阳性菌,两种革兰氏阴性菌和三种假丝酵母菌的体外抗菌活性。与标准药物相比。微生物学结果表明,新合成的2-(苄基/对氯苄基)-5-[(取代的噻吩基/苯基/苯硫甲基/苄基)羰基氨基]苯并恶唑衍生物(3-12)具有广谱的活性,其MIC值为对测试的微生物为6.25-100微克/毫升。特别地,具有6.25μg/ ml的MIC值,2-(对-氯苯基)-5-[(2,5-二甲基苯基)羰基氨基]苯并恶唑4显示出与白色念珠菌相同的作为标准药物克霉唑的活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号